APA Daily Bulletin - Day 2, 2008 - (Page 5) May 5, 2008 The Daily BULLETIN 5 Monday CONVERSATIONS Actress, author Patty Duke to tell her story Patty Duke is best known for her roles in the Patty Duke Show, the cult movie classic Valley of the Dolls, and her Oscar-winning role in The Miracle Worker. But today she’s winning awards for her role as a mental health advocate instead. Duke, whose real name is Anna Pearce, will share her story of living with bipolar disorder during the “Conversations” event Tuesday at 5:30 p.m. in Hall D of the Washington Convention Center. had ever heard. They described how it felt to be me,” she wrote. A few years after her diagnosis, Pearce wrote her best-selling autobiography, Call Me Anna, and revealed her disorder to the world. She became a spokeswoman for mental health, and was one of the first celebrities to speak openly about mental illness. She was recently appointed to the National Advisory Council of the Center for Mental Health Services. In 2006 she received the Lionel Aldridge Award from the National Alliance on Mental Illness, and the first Rebecca’s Dream Legacy of Life Award from the Depression and Bipolar Support Alliance. She was awarded an honorary doctorate from the University of North Florida for her work in advancing awareness of mental health issues. She has an online blog, “The Patty Duke Online Center for Mental Wellness,” that offers an open forum for discussion for those with mental illness. In tomorrow evening’s session, she will share her experience of living with bipolar disorder in a conversational interview with Altha J. Stewart, M.D., former president of the American Psychiatric Foundation. Despite her illness, Anna “Patty Duke” Pearce had an extremely successful stage, television, and movie career that includes two Golden Globe awards, three Emmy Awards, and nine total Emmy nominations. She starred in feature films including Prelude to a Kiss; Me, Natalie; and Billie. She has made dozens of television movies, including The Babysitter, and Sweet Charlie, which was so successful it was later released theatrically. She has served as President of the Screen Actors Guild and tried her hand at producing and directing. She lives in Idaho with her husband and youngest child and continues to act. Realize the possibilities Patty Duke Pearce began to experience symptoms of severe depression when she was a young adult, and by age 19 had been committed to a hospital for her uncontrollable highs and suicidal lows. She wasn’t diagnosed, however, until 1982 — about 16 years later. In her 1992 book, A Brilliant Madness: Living with Manic Depressive Illness, she described relief as her doctor told her she was manicdepressive. “But the words made sense. As my psychiatrist said them, I nodded my head as if I had known this all along. They were the best two words I ■ ■ Gina, 3 7 Real patient, Manager Diagnosis: bipolar disorder Last episode: mixed Effectively treats acute manic and mixed episodes Well-established tolerability profile ■ ■ Target 120–160 mg/day on Day 2 Initiate dosing at 80 mg/day with meals The APA Daily Bulletin is published by the APA’s Office of Communications & Public Affairs as a service to the members of the American Psychiatric Association. Produced by TriStar Publishing, Inc. Managing Editor Gionne A. Johnson Production Editor Erin E. Jungmeyer Art & Design Elisabeth Nord American Psychiatric Association 1000 Wilson Boulevard, Ste. 1825 Arlington, VA 22209 Phone: 703-907-8640 press@psych.org • www.psych.org TriStar Publishing, Inc. 7285 W. 132nd Street, Suite 300 Overland Park, KS 66213 Phone: 913-491-4200 Fax: 913-491-4202 www.tristarpub.com GEODON is indicated for the treatment of acute manic or mixed episodes associated with bipolar disorder, with or without psychotic symptoms. Elderly patients with dementia-related psychosis treated with atypical antipsychotic drugs are at an increased risk of death compared to placebo. GEODON is not approved for the treatment of patients with dementia-related psychosis. GEODON is contraindicated in patients with a known history of QT prolongation, recent acute myocardial infarction, or uncompensated heart failure, and should not be used with other QT-prolonging drugs. GEODON has been associated with prolongation of the QTc interval. In some drugs, QT prolongation has been associated with torsade de pointes, a potentially fatal arrhythmia. Patients who are at risk for significant electrolyte disturbances should have baseline measurements performed before initiating GEODON. Patients on diuretics should be monitored. As with all antipsychotic medications, a rare and potentially fatal condition known as neuroleptic malignant syndrome (NMS) has been reported with GEODON. NMS can cause hyperpyrexia, muscle rigidity, diaphoresis, tachycardia, irregular pulse or blood pressure, cardiac dysrhythmia, and altered mental status. If signs and symptoms appear, immediate discontinuation, treatment, and monitoring are recommended. Prescribing should be consistent with the need to minimize tardive dyskinesia (TD), a potentially irreversible dose- and durationdependent syndrome. If signs and symptoms appear, discontinuation should be considered since TD may remit partially or completely. Hyperglycemia-related adverse events, sometimes serious, have been reported in patients treated with atypical antipsychotics. There have been few reports of hyperglycemia or diabetes in patients treated with GEODON, and it is not known if GEODON is associated with these events. Patients treated with an atypical antipsychotic should be monitored for symptoms of hyperglycemia. Precautions include the risk of rash, orthostatic hypotension, and seizures. The most common adverse events associated with GEODON in bipolar mania were somnolence, extrapyramidal symptoms, dizziness, akathisia, and abnormal vision. In short-term schizophrenia clinical trials, 10% of GEODON-treated patients experienced a weight gain of ≥7% of body weight vs 4% for placebo. Individual results may vary. Please see brief summary of prescribing information on adjacent page. For more information, please visit www.pfizerpro.com/GEODON http://www.psych.org http://www.pfizerpro.com/GEODON http://www.pfizerpro.com/GEODON http://www.tristarpub.com
Table of Contents Feed for the Digital Edition of APA Daily Bulletin - Day 2, 2008 Contents Alexandra Symonds Award Sports Psychiatry Conversations APA Daily Bulletin - Day 2, 2008 APA Daily Bulletin - Day 2, 2008 - Contents (Page 1) APA Daily Bulletin - Day 2, 2008 - Contents (Page 2) APA Daily Bulletin - Day 2, 2008 - Alexandra Symonds Award (Page 3) APA Daily Bulletin - Day 2, 2008 - Sports Psychiatry (Page 4) APA Daily Bulletin - Day 2, 2008 - Conversations (Page 5) APA Daily Bulletin - Day 2, 2008 - Conversations (Page 6) APA Daily Bulletin - Day 2, 2008 - Conversations (Page 7) APA Daily Bulletin - Day 2, 2008 - Conversations (Page 8)
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.